Rexulti 4 mg, Filmtabletten - 28 Swissmedic Key 66475006 Registration Holder Lundbeck (Schweiz) AG Name Rexulti 4 mg, Filmtabletten Date of registration 17.07.2018 Introduction of Sequence 17.07.2018 ATC-Classification Brexpiprazole (N05AX16) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 01.05. Show package size 28 Index Therapeuticus (Swissmedic) 01.05. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 146.06 Limitation No Deductible 10 % Consumer price 184.25 Feedback FB Daily cost GTIN 7680664750065 Medication Code Synthetika Pharmacode 7435362 Disponibility
Composition brexpiprazolum 4 mg, lactosum monohydricum 44.4 mg, maydis amylum, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, magnesii stearas, Überzug: hypromellosum, talcum, E 171, pro compresso obducto. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Brexpiprazolum 4 mg
BAG: Active Agent Dose Brexpiprazolum 4 mg
Inactive agents Dose additional_information Cellulosum Microcristallinum E 171 color. Hydroxypropylcellulosum Hydroxypropylcellulosum Substitutum Humile Hypromellosum Überzug Lactose Monohydrate 44.4 mg Magnesii Stearas Maydis Amylum Pro Compresso Obducto Talcum
Source Data was imported : 12.01.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
